The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 27, 2014
Filed:
Feb. 26, 2010
Steven B. Porter, Mill Valley, CA (US);
Williamson Ziegler Bradford, Ross, CA (US);
Patrick F. Smith, Pleasanton, CA (US);
Ellen S. Yetzer, San Francisco, CA (US);
Abel DE LA Rosa, Alpharetta, GA (US);
Michael D. Rogers, Chapel Hill, NC (US);
William T. Symonds, Cary, NC (US);
Steven B. Porter, Mill Valley, CA (US);
Williamson Ziegler Bradford, Ross, CA (US);
Patrick F. Smith, Pleasanton, CA (US);
Ellen S. Yetzer, San Francisco, CA (US);
Abel De La Rosa, Alpharetta, GA (US);
Michael D. Rogers, Chapel Hill, NC (US);
William T. Symonds, Cary, NC (US);
Hoffmann la Roche Inc., Nutley, NJ (US);
Pharmasset, Inc., Princeton, NJ (US);
Roche Palo Alto LLC, Palo Alto, CA (US);
Abstract
Embodiments disclosed in the present application relate to a composition that can include a hepatitis C viral polymerase inhibitor, or pharmaceutically acceptable salt or prodrug thereof and a hepatitis C viral protease inhibitor, or pharmaceutically acceptable salt or prodrug thereof. Additional embodiments disclosed relate to methods for treating a disease condition such as a hepatitis C virus infection, liver fibrosis and/or impaired liver function with a hepatitis C viral polymerase inhibitor, or pharmaceutically acceptable salt or prodrug thereof and a hepatitis C viral protease inhibitor, or pharmaceutically acceptable salt or prodrug thereof.